Drug interactions
Immunoglobulin + Nipocalimab
Severity: Moderate
Immunoglobulin and Nipocalimab: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Nipocalimab blocks FcRn, which may reduce exposure to and efficacy of immunoglobulin products. Therapeutic IgG may be cleared faster.
What this interaction means in plain words
Immunoglobulin and Nipocalimab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Immunoglobulin belongs to Miscellaneous; Nipocalimab belongs to Miscellaneous.
Why it happens
FcRn blockade reduces IgG recycling, increasing catabolism of IgG-based therapies.
What to do
Monitor clinical response to the immunoglobulin product and adjust therapy as needed. Reassess need for concurrent use.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Immunoglobulin and Nipocalimab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Immunoglobulin
- Immunoglobulin + Pozelimab Major
- Dinutuximab beta + Immunoglobulin Moderate
- Efgartigimod alfa + Immunoglobulin Moderate
- Immunoglobulin + Rozanolixizumab Moderate
Frequently asked questions
Can I take Immunoglobulin with Nipocalimab?
MediHelp rates the interaction as moderate. Immunoglobulin and Nipocalimab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nipocalimab blocks FcRn, which may reduce exposure to and efficacy of immunoglobulin products. Therapeutic IgG may be cleared faster.
How serious is the interaction between Immunoglobulin and Nipocalimab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response to the immunoglobulin product and adjust therapy as needed. Reassess need for concurrent use.
What other medicines interact with Immunoglobulin?
MediHelp also lists interactions of Immunoglobulin with, for example, Pozelimab, Dinutuximab beta, Efgartigimod alfa. The full list is on the Immunoglobulin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
